| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/01/2000 | CN1245707A Chinese medicine for curing AIDS and carcinomatosis |
| 03/01/2000 | CN1049893C Valaciclovic hydrochloride and its preparing method, and its use |
| 03/01/2000 | CN1049823C Biological bacteriostat and its producing method |
| 02/29/2000 | US6031102 Optically active pyridonecarboxylic acid derivatives |
| 02/29/2000 | US6031096 Acyclovir diester derivatives |
| 02/29/2000 | US6031093 Solid salts of clavulanic acid |
| 02/29/2000 | US6031000 Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use |
| 02/29/2000 | US6030989 Hemoregulatory compounds |
| 02/29/2000 | US6030985 Stroke, schizophrenia, antianxiolytic and antihypoxia agents, analgesics; neurodegenerative disorders, e.g., nerve degeneration and/or necrosis; hyperglycemic, antiepileptic and antiinflammatory agents; drug abuse; |
| 02/29/2000 | US6030981 Phenanthridine derivatives, methods of producing them and medicaments containing phenanthridine derivatives |
| 02/29/2000 | US6030978 Exhibit fungicidal effect or growth-inhibitory effect against fungi including cutaneous filamentous fungus, such as epidermophyton, microsporum, trichophyton, sporothrix schenckii, aspergillus or candida; nontoxicity; |
| 02/29/2000 | US6030957 Inhibiting hiv(human immunodeficiency virus) reverse transciptase in cells infected with hiv by administering to infected cells arylphosphate derivative of 2',3'-didehydro-2',3'-dideoxythymidine |
| 02/29/2000 | US6030946 Reversible cysteine protease inhibitors |
| 02/29/2000 | US6030944 Cyclohexapeptidyl bisamine compounds |
| 02/29/2000 | US6030835 Methods and composition for identifying group a streptococcus |
| 02/29/2000 | US6030785 Incubating a mixture containing pkr protein kinase, a viral protein containing an interferon sensitivity determining region, and an agent to be tested; then measuring the protein kinase activity where activity indicates an antiviral agent |
| 02/29/2000 | US6030772 Neutralizing antibodies against HIV infection |
| 02/29/2000 | US6030626 Method for preparing the fimbrin protein of Haemophilus influenzae |
| 02/29/2000 | US6030625 Bordetella pertussis and Bordetella parapertussis strains |
| 02/29/2000 | US6030622 Herbal extract composition and method with immune-boosting capability |
| 02/29/2000 | US6030619 Molecular mimetics of meningococcal B epitopes |
| 02/29/2000 | US6030612 Antimicrobial uses of multifunctional enzyme |
| 02/29/2000 | CA2155322C Crystalline ceftiofur free acid |
| 02/29/2000 | CA2077753C Purified gp120 composition retaining natural conformation |
| 02/29/2000 | CA2002648C 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives |
| 02/24/2000 | WO2000009734A2 Methods and compositions for use in spliceosome mediated rna trans-splicing |
| 02/24/2000 | WO2000009702A1 Cold-adapted equine influenza viruses |
| 02/24/2000 | WO2000009695A2 Drug targets in candida albicans |
| 02/24/2000 | WO2000009690A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | WO2000009665A1 Engineered antigen-presenting cells expressing an array of antigens and uses thereof |
| 02/24/2000 | WO2000009616A1 Biologically active fraction of vegetable melanin, process for its production and its use |
| 02/24/2000 | WO2000009558A1 Hepatitis c inhibitor peptides |
| 02/24/2000 | WO2000009553A2 Antimicrobial peptides isolated from the skin of american frogs |
| 02/24/2000 | WO2000009550A1 Vanadate resistance glycosylation 4 gene |
| 02/24/2000 | WO2000009543A2 Hepatitis c inhibitor tri-peptides |
| 02/24/2000 | WO2000009542A1 SERINE PROTEASE INHIBITORS COMPRISING α-KETO HETEROCYCLES |
| 02/24/2000 | WO2000009541A1 nrdE |
| 02/24/2000 | WO2000009531A2 β-L-2'-DEOXY-NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS B |
| 02/24/2000 | WO2000009512A2 Bipyridine manganese complexes |
| 02/24/2000 | WO2000009510A1 Photocyclized rapamycins |
| 02/24/2000 | WO2000009507A1 Phenyl yanthine derivatives |
| 02/24/2000 | WO2000009504A1 Substituted 1,8-naphthyridin-4(1h)-ones as phosphodiesterase 4 inhibitors |
| 02/24/2000 | WO2000009503A1 Integrin receptor antagonists |
| 02/24/2000 | WO2000009492A1 Tace inhibitors |
| 02/24/2000 | WO2000009485A1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 02/24/2000 | WO2000009475A1 Amine derivatives |
| 02/24/2000 | WO2000009168A1 A method of transducing mammalian cells, and products related thereto |
| 02/24/2000 | WO2000009167A1 Virally-mediated targeting of drugs and genetic material |
| 02/24/2000 | WO2000009158A1 Assay for assembly of herpes simplex virus capsid |
| 02/24/2000 | WO2000009157A1 Protein delivery system using human papillomavirus virus-like particles |
| 02/24/2000 | WO2000009156A1 Non-virulent porphyromonas gingivalis mutant |
| 02/24/2000 | WO2000009154A1 Bacterial superantigen vaccines |
| 02/24/2000 | WO2000009150A2 Cytokine and cytokine receptor, agonist, antagonist and/or antibody combination for therapeutic use |
| 02/24/2000 | WO2000009137A2 Aminosterol compounds and uses thereof |
| 02/24/2000 | WO2000009114A1 Methods for treating viral infections using a compound capable of inhibiting microtubules |
| 02/24/2000 | WO2000009107A2 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders |
| 02/24/2000 | WO2000009101A2 Use of estrogenic compounds as anti-fungal agents |
| 02/24/2000 | WO2000009086A2 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods |
| 02/24/2000 | WO2000001345A3 Use of an amphipathic compound for providing an adjuvant to a subunit vaccine |
| 02/24/2000 | WO1999062538A8 Alpha-keto oxadiazoles as serine protease inhibitors |
| 02/24/2000 | WO1999062504A3 Topical administration of oxazolidinones for transdermal delivery |
| 02/24/2000 | WO1999059525A3 Broad spectrum microbicidal and spermicidal compositions, devices, and methods |
| 02/24/2000 | WO1999058684A3 Compounds from moraxella catarrhalis |
| 02/24/2000 | WO1999045788A8 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 02/24/2000 | DE19837638A1 New arylsulfonamides and analogs, are cannabinoid receptor agonists used e.g. for treating neurodegenerative diseases, pain, convulsions or bacterial or viral infections |
| 02/24/2000 | DE19837627A1 New aminoacid esters of arylsulfonamides are useful for e.g. treating neurodegenerative diseases, pain, convulsions or bacterial or viral infections |
| 02/24/2000 | CA2599597A1 .beta.-l-2'-deoxy-nucleosides for the treatment of hepatitis b |
| 02/24/2000 | CA2341216A1 Bipyridine manganese complexes |
| 02/24/2000 | CA2340700A1 Photocyclized rapamycins |
| 02/24/2000 | CA2340350A1 Phenyl yanthine derivatives |
| 02/24/2000 | CA2340182A1 Tace inhibitors |
| 02/24/2000 | CA2340180A1 1-aryl,-3-arylmethyl-1,8-naphthyridn-2(1h)-ones |
| 02/24/2000 | CA2340086A1 A method of transducing mammalian cells, and products related thereto |
| 02/24/2000 | CA2340085A1 Engineered antigen-presenting cells expressing an array of antigens and uses thereof |
| 02/24/2000 | CA2339634A1 Amine derivatives |
| 02/24/2000 | CA2339405A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | CA2339338A1 Vanadate resistance glycosylation 4 gene |
| 02/24/2000 | CA2339337A1 Drug targets in candida albicans |
| 02/24/2000 | CA2339300A1 Methods and compositions for use in spliceosome mediated rna trans-splicing |
| 02/24/2000 | CA2338885A1 Antimicrobial peptides isolated from the skin of american frogs |
| 02/24/2000 | CA2338878A1 Integrin receptor antagonists |
| 02/24/2000 | CA2338184A1 Bacterial superantigen vaccines |
| 02/24/2000 | CA2336148A1 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders |
| 02/24/2000 | CA2280582A1 Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus |
| 02/23/2000 | EP0980866A2 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 02/23/2000 | EP0980434A1 Intracellular production of hepatitis c e1 and e2 truncated polypeptides |
| 02/23/2000 | EP0980390A2 Human-cd28 specific monoclonal antibodies for antigen non-specific activation of t-lymphocytes |
| 02/23/2000 | EP0980389A1 Antigen |
| 02/23/2000 | EP0980387A1 Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays |
| 02/23/2000 | EP0980377A1 Anti-viral pyrimidine nucleoside analogues |
| 02/23/2000 | EP0980254A1 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity |
| 02/23/2000 | EP0980249A1 Use of cd26 inhibitor for the manufacture of a medicament for the treatment of hiv |
| 02/23/2000 | EP0980248A1 Improvements in or relating to long-acting antimicrobials |
| 02/23/2000 | EP0980204A1 76 kDa, 32 kDa, AND 50 kDa HELICOBACTER POLYPEPTIDES AND CORRESPONDING POLYNUCLEOTIDE MOLECULES |
| 02/23/2000 | EP0980203A1 Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases |
| 02/23/2000 | CN1245493A Asymmetric synthesis of benzoxazinones |
| 02/23/2000 | CN1245431A Medical composition and use thereof for manufacture of topical barrir formulation, UV-radiation absorbing formulation, or antiviral, antifungal, or antiinflammatory formulation |
| 02/23/2000 | CN1245428A Use of 7-(2-oxa-5,8-diazabicyclo [4,3,0] non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for treatment of helicobacter pylori infections and associated gastroduodenal |
| 02/23/2000 | CN1245399A Method of biological control |
| 02/23/2000 | CN1245398A Method of biological control |